Gujarat Kidney & Super Speciality consolidated net profit rises 293.75% in the March 2026 quarter,
Net profit of Gujarat Kidney & Super Speciality rose 293.75% to Rs 5.04 crore in the quarter ended March 2026 as against Rs 1.28 crore during the previous quarter ended March 2025. Sales rose 212.68% to Rs 30.58 crore in the quarter ended March 2026 as against Rs 9.78 crore during the previous quarter ended March 2025.For the full year,net profit rose 64.72% to Rs 15.50 crore in the year ended March 2026 as against Rs 9.41 crore during the previous year ended March 2025. Sales rose 103.80% to Rs 82.01 crore in the year ended March 2026 as against Rs 40.24 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales30.589.78 213 82.0140.24 104 OPM %20.6026.79 -32.8541.13 - PBDT6.192.50 148 25.9316.06 61 PBT4.691.60 193 21.2312.77 66 NP5.041.28 294 15.509.41 65 Powered by Capital Market - Live News
Gujarat Kidney & Super Speciality to announce Quarterly Result,
Gujarat Kidney & Super Speciality will hold a meeting of the Board of Directors of the Company on 28 May 2026.
Gujarat Kidney & Super Speciality postpones board meeting,
Gujarat Kidney & Super Speciality has postponed the meeting of the Board of Directors which was scheduled to be held on 13 February 2026. The meeting will now be held on 14 February 2026.Powered by Capital Market - Live News
Gujarat Kidney & Super Speciality schedules board meeting,
Gujarat Kidney & Super Speciality will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now